The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inhibition of Isoprenylation: A Translational Study of Lovastatin and Paclitaxel in Prostate Cancer.
 
Yoanna S Pumpalova
No Relationships to Disclose
 
Margaret M. Kozak
No Relationships to Disclose
 
Rie von Eyben
No Relationships to Disclose
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Merck, Genentech, Ipsen
Consulting or Advisory Role - Celgene; ipsen
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); EpicentRx (Inst); Forty seven (Inst); Genentech/Roche (Inst); Ipsen (Inst); Merck (Inst); Newlink Genetics (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); Sun Pharma (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Merck
 
Pamela L. Kunz
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Advanced Accelerator Applications (Inst); Dicerna (Inst); Esanex (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lexicon (Inst); Merck (Inst); Oxigene (Inst)
 
Daniel Tandel Chang
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
 
Sigurdis Haraldsdottir
Stock and Other Ownership Interests - Seagen (I)
Consulting or Advisory Role - Genentech/Roche; Ipsen; Merck
Research Funding - Aduro Biotech; EpicentRx; Forty Seven; Genentech/Roche; Merck; Newlink Genetics; XBiotech